Barclays has initiated coverage on two nuclear newcomers, Oklo and NuScale Power, highlighting small modular reactors (SMRs) as a promising solution to the world’s growing energy demands.

Genpact, an agentic and advanced technology solutions company, has announced the launch of the Genpact Insurance Policy Suite ...

Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...